跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen - TGA Drug Approval Details
Approvals
/
TGA
/
HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen
Approved
STANDARD
HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
466f781ff8ec2979
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
466f781ff8ec2979
Product Name
HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen
Artg Id
407873
Artg Name
HYRIMOZ adalimumab 80 mg/0.8 mL solution for injection pre-filled pen
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2024-05-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/844208fc05e5f943990d8d657657ece4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/597eeaa5096c6786e670407cbc37b987.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
466f781ff8ec2979
Type
Standard
Back to TGA Approvals